What is pcv vaccine in india?

The pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PPSV23) protect against pneumococcal infections, which are caused by bacteria.

The bacteria spread through person-to-person contact and can cause such serious infections as pneumonia, blood infections, and bacterial meningitis.

PCV13 protects against 13 types of pneumococcal bacteria (which cause the most common pneumococcal infections in kids). PPSV23 protects against 23 types. These vaccines not only prevent infections in children who are immunized, but also help stop the infections from spreading to others.

PCV and PPSV Immunization Schedules

PCV13 immunizations are given to all infants as a series of 4 injections:

the first at 2 months of age, then at 4 months, 6 months, and 12–15 months.

Some kids older than age 2 also might need a shot of PCV13; for example, if they have missed one or more shots or if they have a chronic health condition (such as heart or lung disease) or one that weakens the immune system like asplenia, HIV infection, etc. A doctor can decide when and how typically a child will need to receive PCV13.

PPSV23 immunizations are recommended as added protection against pneumococcal disease in kids 2–18 years old who have certain chronic health conditions, including heart, lung, or liver disease.

Why Are the PCV and PPSV Vaccines Recommended?

Children younger than 2 years, recent adults over sixty five, and people with certain medical conditions are at high risk of developing serious pneumococcal infections. These vaccines are very effective at preventing severe disease, hospitalization, and even death.

Possible Risks of PCV and PPSV Vaccines

Kids could have redness, tenderness, or swelling where the shot was given. A child also might have a fever when obtaining the shot.

Routine vaccination:

Minimum age: 6 weeks

Both PCV10 and PCV13 square measure authorized  for youngsters from half dozen weeks to five years aged.

Catch-up vaccination:

Administer one dose of PCV13 or PCV10 to all or any healthy kids aged twenty four through fifty nine months who aren’t fully immunized for their age.

For PCV one3: Catch up in 6-12 months: a pair of doses four weeks apart and 1 booster; 12-23 months: a pair of doses eight weeks apart; twenty four mo & above: single dose

Pneumococcal disease is common in young children, but older adults are at greatest risk of serious illness and death. In the United States, there are 2 kinds of vaccines that help prevent pneumococcal disease

CDC recommends pneumococcal vaccination for all children younger than 5 years old and all adults 65 years or older. In certain situations, other children and adults should also get pneumococcal vaccines. Below is more information about who should and should not get each type of pneumococcal vaccine.

Talk to your or your child’s doctor about what is best for your specific situation.

CDC recommends PCV13 or PCV15 for

For those who have never received any pneumococcal conjugate vaccine, CDC recommends PCV15 or PCV20 for

Adults who received an earlier pneumococcal conjugate vaccine (PCV13 or PCV7) should talk with a vaccine provider to learn about available options to complete their pneumococcal vaccine series.

Adults 65 years or older have the option to get PCV20 if they have already received

and

These adults can talk with their doctor and decide, together, whether to get PCV20.

CDC recommends PPSV23 for

Because of age or health conditions, some people should not get certain vaccines or should wait before getting them. Read the guidelines below specific to pneumococcal vaccines and ask your or your child’s doctor for more information.

In addition, tell the person who is giving you or your child a pneumococcal vaccine if:

There are 4 pneumococcal vaccines licensed for use in the United States by the Food and Drug Administration:

PCV15 and PCV20 are new vaccines, so there are no data on how well these vaccines work in real-world conditions. However, these vaccines were approved because clinical trial data indicate they cause an immune response similar to PCV13, which has been shown to protect against serious pneumococcal infections.

Studies* show that getting at least 1 shot of PCV13 protects:

Studies* show that getting 1 shot of PPSV23 protects:

A recent media report in a national daily has claimed shortage of Pneumococcal (PCV) vaccine across the country. It quotes State health officials (including SIO, Maharashtra) noting that tendering delay has led to the disruption in schedules of tens of thousands of children across the country for over a month.

The news report is ill-informed and provides erroneous information.

As per data available till 7th October 2022, sufficient doses of PCV Vaccine are available. A total of 70,18,817 (70.18 lakh) doses of PCV are available with all States and UTs. This includes 3,01,794 (3.01 lakh) doses of PCV with the State of Maharashtra.

Further, as per the HMIS data of Union Ministry of Health & Family Welfare, in the period January 2022 to September 2022, a total of 3,27,67,028 (3.27 crore) doses of PCV supplied by the Union Govt have been utilized by all the States and UTs. This includes 18,80,722 (18.80 lakh) doses of PCV utilized in the State of Maharashtra.

The supplies against procurement of PCV for the year 2022-23 have also commenced to the States & UTs.

Pneumonia is one of the major causes of child mortality and Government of India has taken proactive steps to effectively address this problem.

Pneumococcal Conjugate Vaccine (PCV) was introduced by Govt. of India in 2017 in a phased manner across the most affected five states of India viz., Bihar, Himachal Pradesh, Madhya Pradesh, Rajasthan and Uttar Pradesh. Thereafter, the PCV under the Universal Immunization Programme (UIP) has been expanded throughout the country.

The PCV is now an integral part of India’s Universal Immunization Programme (UIP) and is available free of cost to the entire birth cohort of 27.1 million. It is given in three dose schedule (6 weeks, 14 weeks and booster at 9-12 months).

****

MV

HFW/MythsvsFacts-Pneumococcal Vaccine Shortage/8th October2022/4

The pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PPSV23) protect against pneumococcal infections, which are caused by bacteria. The bacteria spread through person-to-person contact and can cause such serious infections as pneumonia, blood infections, and bacterial meningitis.